Characteristics of neurons and glia in the brain of Fukuyama type congenital muscular dystrophy

Acta Myologica

Volumn 27, Issue JULY, 2008, Pages 9-13

  Yamamoto, T ^a   Kato, Y ^a   Kawaguchi Niida, M ^a   Shibata, N ^a   Osawa, M ^a   Saito, K ^a   Kroger S ^b   Kobayashi, M ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

Fukuyama type congenital muscular dystrophy (FC MD); Glia; Neuron

Indexed keywords

6 N CARBOXYMETHYLLYSINE; ALPHA DYSTROGLYCAN; CYCLIN D1; DYSTROPHIN; FUKUTIN; KI 67 ANTIGEN; MANGANESE SUPEROXIDE DISMUTASE; MESSENGER RNA; PROTEIN C JUN;

ASTROCYTE; BRAIN NERVE CELL; CONFERENCE PAPER; CORTICAL DYSPLASIA; DEMYELINATION; DISEASE SEVERITY; FUKUYAMA CONGENITAL MUSCULAR DYSTROPHY; GLIA CELL; HUMAN; NEUROFIBRILLARY TANGLE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION;

ASTROCYTES; BASEMENT MEMBRANE; BLOTTING, WESTERN; CENTRAL NERVOUS SYSTEM; CEREBRAL CORTEX; GLYCOSYLATION; HUMANS; IMMUNOHISTOCHEMISTRY; LYSINE; MEMBRANE PROTEINS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES; NEUROGLIA; NEURONS;

EID: 51649111748     PISSN: 11282460     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (22)

1. Schessl J, Zou Y, Bönnemann CG. Congenital muscular dystrophies and the extracellular matrix. Semin Pediatr Neurol 2006;13:80-9.
2. Osawa M, Sumida S, Suzuki N, et al. Fukuyama type congenital progressive muscular dystrophy. In: Fukuyama Y, Osawa M, Saito K, editors. Congenital Muscular Dystrophies. Amsterdam: Elsevier; 1997. p. 31-68.
3. Kobayashi K, Nakahori Y, Miyake M, et al. An ancient retrotransposal insertion causes Fukuyama-type congenital muscular dystrophy. Nature 1998;394:388-92.
4. Hayashi YK, Ogawa M, Tagawa K, et al. Selective deficiency of α-dystroglycan in Fukuyama-type congenital muscular dystrophy. Neurology 2001;57:115-21.
5. Martin PT. The dystroglycanopathies: The new disorders of O-linked glycosylation. Semin Pediatr Neurol 2005;152:152-8.
6. Manya H. Sakai K, Kobayashi K, et al. Loss-of-function of an N-acetylglucosaminyltransferase, POMGnT1, in muscle-eye-brain disease. Biochem Biophys Res Commun 2003;306:93-7.
7. Takahashi S, Sasaki T, Manya H, et al. A new β1,2-N-acetylglucosaminyltransferase that may play a role in the biosynthesis of mammalian O-mannosyl glycans. Glycobiology 2001;11:37-45.
8. Manya H, Chiba A, Yoshida A, et al. Demonstration of mammalian protein O-mannosyltransferase activity: coexpression of POMT1 and POMT2 required for enzymatic activity. Proc Acad Natl Sci USA 2004;101:500-5.
9. Yamamoto T, Kato Y, Kawaguchi M, et al. Expression and localization of fukutin. POMGnT1 and POMT1 in the central nervous system: consideration for functions of fukutin. Med Electron Microsc 2004;37:200-7.
10. Saito Y, Kobayashi M, Itoh M, et al. Aberrant neuronal migration in the brainstem of Fukuyama-type congenital muscular dystrophy. J Neuropathol Exp Neurol 2003;62:497-508.
11. Chiyonobu T, Sasaki J, Nagai Y, et al. Effects of fukutin deficiency in the developing mouse brain. Neuromusc Disord 2005;15:416-26.
12. Yamamoto T, Kato Y, Karita M, et al. Fukutin expression in glial cells and neurons: implication in the brain lesions of Fukuyama congenital muscular dystrophy. Acta Neuropathol 2002;104:217-24.
13. Yamamoto T, Kawaguchi M, Sakayori N, et al. Intracellular binding of fukutin and α-dystroglycan: relation glycosylation of α-dystroglycan. Neurosci Res 2006;56:391-9.
14. Yamamoto T, Shibata N, Kobayashi M, et al. Oxidative stress in the brain of Fukuyama type congenital muscular dystrophy: immunohistochemical study on astrocytes. J Child Neurol 2002;17:793-9.
15. Sasaki J, Ishikawa K, Kobayashi K, et al. Neuronal expression of the fukutin gene. Hum Mol Genet 2000;9:3083-90.
16. Schröder JE, Tegeler MR, Großhans U, et al. Dystroglycan regulates structure, proliferation and differentiation of neuroepithelial cells in the developing vertebrate CNS. Dev Biol 2007; 307:62-78.
17. Moore SA, Saito F, Chen J, et al. Deletion of brain dystroglycan recapitulates aspects of congenital muscular dystrophy. Nature 2002;418:422-5.
18. Saito Y, Yamamoto T, Mizuguchi M, et al. Altered glycosylation of α-dystroglycan in neurons of Fukuyama congenital muscular dystrophy brains. Brain Res 2006;1075:223-8.
19. Saito F, Masaki T, Saito Y, et al. Defective peripheral nerve myelination and neuromuscular junction formation in fukutin-deficient chimeric mice. J Neurochem 2007;101:1712-22.
20. Colognato H, Galvin J, Wang Z, et al. Identification of dystroglycan as a second laminin receptor in oligodentrocytes, with a role in myelination. Development 2007;134:1723-36.
21. del Zoppo GJ, Milner R, Mabuchi T, et al. Vascular matrix adhesion and the blood-brain barrier. Biochem Soc Transac 2006;34:1261-6.
22. Nico B, Nicchia GP, Frigeri A, et al. Altered blood-brain barrier development in dystrophic mdx mice. Neuroscience 2004;125:921-35.